37.77
price up icon0.56%   0.21
after-market After Hours: 37.65 -0.12 -0.32%
loading
Harrow Inc stock is traded at $37.77, with a volume of 496.79K. It is up +0.56% in the last 24 hours and down -21.61% over the past month. Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
See More
Previous Close:
$37.56
Open:
$37.68
24h Volume:
496.79K
Relative Volume:
0.71
Market Cap:
$1.40B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-39.34
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
-1.95%
1M Performance:
-21.61%
6M Performance:
+52.48%
1Y Performance:
-16.18%
1-Day Range:
Value
$36.77
$38.53
1-Week Range:
Value
$36.20
$39.30
52-Week Range:
Value
$20.85
$54.19

Harrow Inc Stock (HROW) Company Profile

Name
Name
Harrow Inc
Name
Phone
615.733.4731
Name
Address
1A BURTON HILLS BLVD, NASHVILLE, CA
Name
Employee
382
Name
Twitter
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
HROW's Discussions on Twitter

Compare HROW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
HROW
Harrow Inc
37.77 1.39B 154.15M -33.58M -20.74M -0.96
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Harrow Inc Stock (HROW) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-11-25 Initiated Cantor Fitzgerald Overweight
Jun-12-25 Initiated BTIG Research Buy
Jun-10-25 Initiated William Blair Outperform
Feb-06-25 Initiated H.C. Wainwright Buy
Dec-04-24 Reiterated B. Riley Securities Buy
Apr-11-24 Initiated Craig Hallum Buy
Sep-08-22 Resumed B. Riley Securities Buy
Oct-14-21 Resumed B. Riley Securities Buy
Sep-24-21 Initiated Aegis Capital Buy
Jul-02-21 Initiated Ladenburg Thalmann Buy
View All

Harrow Inc Stock (HROW) Latest News

pulisher
06:20 AM

Best data tools to analyze Harrow Inc. stockWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com

06:20 AM
pulisher
06:10 AM

Can Harrow Inc. stock sustain market leadershipWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com

06:10 AM
pulisher
05:56 AM

How Harrow Inc. stock reacts to global recession fearsProfit Target & Weekly Market Pulse Alerts - newser.com

05:56 AM
pulisher
04:52 AM

Why Harrow Inc. stock is in analyst buy zone2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

04:52 AM
pulisher
01:29 AM

What insider trading reveals about Harrow Inc. stock2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com

01:29 AM
pulisher
Oct 30, 2025

What risks investors should watch in Harrow Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Harrow Inc. stock pay special dividends2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Corrado Advisors LLC Purchases Shares of 7,366 Harrow, Inc. $HROW - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Custom watchlist performance reports with Harrow Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What is the fair value of Harrow Inc. stock now2025 Price Targets & Free Verified High Yield Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Analyzing Harrow Inc. with risk reward ratio chartsPortfolio Profit Report & Trade Opportunity Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Key resistance and support levels for Harrow Inc.July 2025 Setups & Verified Swing Trading Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Should you hold or exit Harrow Inc. now2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

D.A. Davidson & CO. Sells 13,255 Shares of Harrow, Inc. $HROW - MarketBeat

Oct 28, 2025
pulisher
Oct 27, 2025

Harrow, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo

Oct 27, 2025
pulisher
Oct 27, 2025

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Kornitzer Capital Management Inc. KS Acquires New Position in Harrow, Inc. $HROW - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Bleakley Financial Group LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Will Harrow Inc. stock keep outperforming rivalsDollar Strength & Real-Time Market Trend Scan - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Weiss Ratings Reaffirms "Sell (E+)" Rating for Harrow (NASDAQ:HROW) - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Sundram Fasteners Limited (SUNDRMFAST) to Launch New Product LineChart Pattern Recognition & Double Or Triple Investment - earlytimes.in

Oct 26, 2025

Harrow Inc Stock (HROW) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Harrow Inc Stock (HROW) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Opaleye Management Inc.
10% Owner
Jun 10 '25
Sale
30.80
15,000
462,033
90,000
Opaleye Management Inc.
10% Owner
Jun 09 '25
Sale
30.37
15,204
461,794
105,000
Opaleye Management Inc.
10% Owner
Jun 03 '25
Sale
30.04
3,000
90,116
122,000
Opaleye Management Inc.
10% Owner
Jun 04 '25
Sale
30.02
1,796
53,907
120,204
Opaleye Management Inc.
10% Owner
May 12 '25
Sale
25.90
10,000
258,959
130,000
Opaleye Management Inc.
10% Owner
May 13 '25
Sale
26.59
5,000
132,945
125,000
BOLL ANDREW R.
Chief Financial Officer
Apr 03 '25
Option Exercise
0.00
346,500
0
914,589
SAHAREK JOHN P.
CEO & President, ImprimisRx
Apr 03 '25
Option Exercise
0.00
277,200
0
576,863
BAUM MARK L
Chief Executive Officer
Apr 03 '25
Option Exercise
0.00
762,300
0
2,899,825
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
30.01
5,000
150,055
140,000
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):